Publications
A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
Scientific Reports. 6:22183 (2016)
How much do we know about drug resistance due to PrEP use? Analysis of experts’ opinion and its influence on the projected public health impact.
PLoS ONE 11(7): e0158620 (2016)
High incidence is not high exposure: What proportion of prevention trial participants are exposed to HIV?
PLoS ONE 10(1): e0115528 (2015)